The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
Abstract
The Benzopyrones are a group of compounds whose members include coumarins and flavonoids. Dietary exposure to benzopyrones is quite significant, as these compounds are found in vegetables, fruit, seeds, nuts, coffee, tea and wine. It is estimated that the average western diet contains approximately 1 g/day of mixed benzopyrones. It is, therefore, not difficult to see why extensive research into their pharmacological and therapeutic properties is underway over many years. Coumarin is a natural substance that has shown anti-tumour activity in vivo, with the effect believed to be due to its metabolites (e.g. 7-hydroxycoumarin). This review is based on recent studies of coumarins and coumarin related compounds. Therefore, the focus will be on these relevant compounds and their therapeutic importance. A recent study has shown that 7-hydroxycoumarin inhibits the release of Cyclin D1, which is overexpressed in many types of cancer. This knowledge may lead to its use in cancer therapy. Esculetin inhibits growth and cell cycle progression by inducing arrest of the G(1) phase in HL-60 leukaemia cells, resulting from the inhibition of retinoblastoma protein phosphorylation. Recent studies investigating the potential of flavonoids as therapeutic agents have suggested they may have use in various therapeutic settings ranging from leukaemia treatment to the treatment of patients with HIV. Genistein is a well-known isoflavone and is a tyrosine kinase inhibitor. Studies have indicated that genistein elicits inhibitory effects on cell growth of various carcinoma cell-lines and may be a potential candidate for cancer therapy. In our research, we have investigated the effects of coumarins and coumarin-related compounds on a panel of cell-lines. The most recent work involves two cell-lines, MCF-7 a breast carcinoma and A549 a lung carcinoma. Microtitre assays were performed along with real-time analysis of cell viability using a biosensor called the Cytosensor microphysiometer. These studies suggest that both genistein and esculetin exerted the most potent inhibitory effect on cell growth in comparison to the other two compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
Pharmacognosy, Phytochemistry, Medicinal Plants
Schmid, R., Bruneton, J., & Hatton, C. K. (1995) · Taxon · doi:10.2307/1223435 · Cited by 911
The natural coumarins : occurrence, chemistry, and biochemistry
Murray, R. D., Méndez, J., & Brown, S. A. (1982) · Andalas University Repository (Andalas University) · Cited by 793
Hsieh, C., Santell, R., Haslam, S. Z., & Helferich, W. G. (1998) · PubMed · Cited by 680
Aronica, S. M., Kraus, W. L., & Katzenellenbogen, B. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8517 · Cited by 670 · cited 1×
“Previous studies have investigated the effects of E2 on ER stimulation and signal transduction [85-87].”
BackgroundCoumarin Metabolism, Toxicity and Carcinogenicity: Relevance for Human Risk Assessment
Lake, B. G. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00010-1 · Cited by 562
The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds
Egan, D., O'kennedy, R., Moran, E., Cox, D., Prosser, E., & Thornes, R. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991449 · Cited by 558
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Agarwal, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00385-3 · Cited by 280
Inhibition of Metastases by Anticoagulants
Hejna, M., Raderer, M., & Zielinski, C. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.22 · Cited by 239
CYP2A6: a human coumarin 7-hydroxylase
Pelkonen, O., Rautio, A., Raunio, H., & Pasanen, M. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00200-0 · Cited by 236
HELLMANN, K. (1968) · Nature · doi:10.1038/220308a0 · Cited by 222
Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani
Wu, J. Y.-C., Fong, W.-F., Zhang, J.-X., Leung, C.-H., Kwong, H.-L., Yang, M.-S., Li, D., & Cheung, H.-Y. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01946-0 · Cited by 221
Estrogen Modulation of G-protein-coupled Receptors
Kelly, M. J., & Wagner, E. J. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00190-3 · Cited by 220
Lack of Effect of Coumarin in Women with Lymphedema after Treatment for Breast Cancer
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Rooke, T. W., Quella, S. K., Novotny, P., Mowat, R. B., Michalak, J. C., Stella, P. J., Levitt, R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400503 · Cited by 178
The MTT assay underestimates the growth inhibitory effects of interferons
Jabbar, S., Twentyman, P., & Watson, J. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.306 · Cited by 177
Chen, H., & Walsh, C. T. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00009-6 · Cited by 166
An Acid Phosphatase Assay for Quantifying the Growth of Adherent and Nonadherent Cells
Yang, T.-T., Sinai, P., & Kain, S. R. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0383 · Cited by 157
Nguyen, D. H. D., Webb, D. J., Catling, A. D., Song, Q., Dhakephalkar, A., Weber, M. J., Ravichandran, K. S., & Gonias, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909575199 · Cited by 147
Treatment with coumarin to prevent or delay recurrence of malignant melanoma
THORNES, R. D., Daly, L., Lynch, G., Breslin, B. K., Browne, H. Y., Browne, H. Y., Corrigan, T. P., Daly, P., Edwards, G., Gaffney, E. F., et al. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377122 · Cited by 140
Tumour Cytochrome P450 and Drug Activation
Patterson, L. H., & Murray, G. I. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394502 · Cited by 126
Maurer, L. H., Herndon, J. E., Hollis, D. R., Aisner, J., Carey, R. W., Skarin, A. T., Perry, M. C., Eaton, W. L., Zacharski, L., Hammond, S., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3378 · Cited by 123
Constantinou, A. I., Kamath, N., & Murley, J. S. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00198-1 · Cited by 116
Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., & di Fronzo, G. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00130-x · Cited by 106
Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinoma
Mohler, J. L., Gomella, L. G., Crawford, E. D., Glodé, L. M., Zippe, C. D., Fair, W. R., & Marshall, M. E. (1992) · The Prostate · doi:10.1002/pros.2990200208 · Cited by 97
The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells
Alblas, J., Slager-Davidov, R., Steenbergh, P. H., Sussenbach, J. S., & van der Burg, B. (1998) · Oncogene · doi:10.1038/sj.onc.1201485 · Cited by 88
Vanscheidt, Rabe, Naser-Hijazi, Ramelet, Partsch, Diehm, Schultz-Ehrenburg, Spengel, Wirsching, Götz, et al. (2002) · VASA · doi:10.1024/0301-1526.31.3.185 · Cited by 70
Tanos, V., Brzezinski, A., Drize, O., Strauss, N., & Peretz, T. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00582-6 · Cited by 70
Phytoestrogens. Friends or foes?
Barrett, J. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104478 · Cited by 68
Pan, S., Huang, Y.-W., Guh, J., Chang, Y.-L., Peng, C.-Y., & Teng, C. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00161-8 · Cited by 68
Biological Screening of Plant Coumarins
Ojala, T. (2001) · Työväentutkimus Vuosikirja · Cited by 64
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin
Jiménez-Orozco, F. A., López-González, J. S., Nieto-Rodrı́guez, A., Velasco-Velázquez, M. A., Molina-Güarneros, J., Mendoza-Patiño, N., Garcı́a-Mondragón, M. J., Galván, P. E., León-Cedeño, F., & Mandoki, J. J. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00263-x · Cited by 62
Marshall, M. E., Butler, K. M., & Fried, A. (1991) · PubMed · Cited by 61
Papazisis, K. T., Zambouli, D., Kimoundri, O., Papadakis, E. S., Vala, V., Geromichalos, G. D., Voyatzi, S., Markala, D., Destouni, E., Boutis, L., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00569-3 · Cited by 53
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
Brady, H. A., Desai, S. J., Gayo, L. M., Khammungkhune, S., McKie, J. A., O'Leary, E. C., Pascasio, L., Sutherland, M. K., Anderson, D. W., Bhagwat, S. S., et al. (2002) · PubMed · Cited by 49
Cooke, D., & O’Kennedy, R. J. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4274 · Cited by 44
Marshall, M. E., Butler, K. M., & Hermansen, D. K. (1990) · The Prostate · doi:10.1002/pros.2990170203 · Cited by 42
Cytokine therapy in renal cell cancer
Vuky, J., & Motzer, R. J. (2000) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(00)00068-5 · Cited by 42
Aisner, J., Goutsou, M., Maurer, L. H., Cooper, R. G., Chahinian, P. A., Carey, R. W., Skarin, A. T., Slawson, R. G., Perry, M. C., & Green, M. R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1230 · Cited by 41
Inhibition of estrogenic stimulation of gene expression by genistein
Ratna, W. N. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01770-8 · Cited by 38
Murakami, A., Yamayoshi, A., Iwase, R., Nishida, J., Yamaoka, T., & Wake, N. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00204-9 · Cited by 38
Vercoutter‐Edouart, A., Lemoine, J., Smart, C. E., Nurcombe, V., Boilly, B., Peyrat, J., & Hondermarck, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01855-x · Cited by 36
Inhibition of adhesion breast cancer cells by anticoagulant drugs and cimetidine.
Bobek, V., Boubelík, M., Kovarik, J. P., & Taltynov, O. (2003) · PubMed · Cited by 27
Mueller, H., Petra, L. O. O. P., Liu, R., Wosikowski, K., Kueng, W., & Eppenberger, U. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18775.x · Cited by 22
Flury, N., Eppenberger, U., & Mueller, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00421.x · Cited by 18
Cytochrome P450 isoform-specific in vitro methods to predict drug metabolism and interactions
Taavitsainen, P. (2001) · Cited by 12
Si, F., Shin, S. H., Biedermann, A., & Ross, G. M. (1999) · Experimental Brain Research · doi:10.1007/s002210050608 · Cited by 10
Cited by
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds
Stefanachi, A., Leonetti, F., Pisani, L., Catto, M., & Carotti, A. (2018) · Molecules · doi:10.3390/molecules23020250 · Cited by 673
Pratap, R., & Ram, V. J. (2014) · Chemical Reviews · doi:10.1021/cr500075s · Cited by 604
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musa, M., Cooperwood, J., & Khan, M. O. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242877 · Cited by 538
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
Küpeli Akkol, E., Genç, Y., Karpuz, B., Sobarzo-Sánchez, E., & Capasso, R. (2020) · Cancers · doi:10.3390/cancers12071959 · Cited by 493
Bioactivities of Phenolics by Focusing on Suppression of Chronic Diseases: A Review
Shahidi, F., & Yeo, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061573 · Cited by 474
Metadata
- Authors
- Lacy, A.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-11-01
- Volume
- 10
- Issue
- 30
- Pages
- 3797-3811
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2168457230
- Cited by
- 635
- References
- 47
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.